CHINESE JOURNAL OF DRUG EVALUATION ›› 2022, Vol. 39 ›› Issue (5): 422-426.

Previous Articles     Next Articles

Research Progress on Adverse Reactions of Donepezil

  

  1. School of Pharmacy, Tianjin Medical University, Tianjin Key Laboratory on Technologies Enabling
         Development of Clinical Therapeutics and Diagnostics, Tianjin 300070, China
  • Received:2022-08-11 Revised:2022-09-28 Online:2022-10-28 Published:2022-10-28

Abstract: Donepezil is one of the second-generation specific reversible central acetylcholinesterase inhibitors (AChEIs). It iswidely applicatedin the treatment of Alzheimer′s disease (AD), vascular dementia and other diseases in clinical practice.In order to provide a scientific basis for clinical applications, this articlesummarized the adverse reactions of donepezil.By reviewing the relevant literature in recent years,it was foundthat the adverse reactions of donepezil weremainly gastrointestinal reactions, arrhythmias and mental disorders.

Key words: font-size:medium, ">Donepezil; Alzheimer′s disease; Adverse reactions; Gastrointestinal reactions

CLC Number: 

[an error occurred while processing this directive]